ChatterBank3 mins ago
Osteoporosis Treatment
3 Answers
Has anyone changed from oral alendronic acid once a week, to an injection of denosumab once every six months, for their osteoporosis treatment?
If you did, what was the criteria for you to change? Thanks.
If you did, what was the criteria for you to change? Thanks.
Answers
Best Answer
No best answer has yet been selected by ethandron. Once a best answer has been selected, it will be shown here.
For more on marking an answer as the "Best Answer", please visit our FAQ.Oral bisphosphonates need to be contra-indicated, poorly tolerated or radiologically proven to be inefficacious in order for the patient to be eligible for Denosumab.
If Denosumab is being used to treat osteoporosis I do believe it's still only licenced for treatment in women at 60mg subcutaneously ever 6 months.
If being used to treat bone mets, it is licenced for men and women at 120mg every 4 weeks.
It can only be initiated for osteoporosis by someone with a special interest in osteoporosis.
If Denosumab is being used to treat osteoporosis I do believe it's still only licenced for treatment in women at 60mg subcutaneously ever 6 months.
If being used to treat bone mets, it is licenced for men and women at 120mg every 4 weeks.
It can only be initiated for osteoporosis by someone with a special interest in osteoporosis.